Mark Yarchoan - Y Combinator Founder of Adventris Pharmaceuticals
Home›Founders›Mark Yarchoan
Mark Yarchoan, Founder of Adventris Pharmaceuticals

Founder at Adventris Pharmaceuticals

Mark Yarchoan, M.D, is an Associate Professor of Medical Oncology at Johns Hopkins. Dr. Yarchoan runs an NCI-funded laboratory focused on developing novel immunotherapies, with a focus on cancer vaccines. He has led multiple international clinical trials of immunotherapy agents including neoantigen-targeted cancer vaccines. Dr. Yarchoan has received multiple honors, including the ASCO Young Investigator Award and the ASCO Career Development Award.

Previously at

The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine
Penn Medicine, University of Pennsylvania Health System
Penn Medicine, University of Pennsylvania Health System
Alumnus of
University of Pennsylvania School of Medicine
University of Pennsylvania School of Medicine
Amherst College
Amherst College